相关实验视频

Updated: Feb 22, 2026

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

作为双重功能瘤基因和免疫调节剂的SLFN5:一项泛癌多组体分析,将预后,免疫逃避和治疗脆弱性联系起来

Fubiao Kang¹, Ziye Yang², Dong Li¹

¹Department of Hepatology, Bethune International Peace Hospital, NO.398, Zhongshan Road West, Shijiazhuang, 050082, People's Republic of China.

Cancer treatment and research communications

|February 20, 2026

概括

这项研究揭示了SLFN5

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
癌症生物学癌症生物学

背景情况:

人类癌症中SLFN5的作用尚未完全理解.
研究SLFN5在瘤进展和免疫反应中的双重功能至关重要.

研究的目的:

阐明SLFN5在乳腺,肝脏和卵巢癌中的瘤和免疫调节功能.
探索SLFN5与瘤攻击性,临床结果和免疫微环境的关联.
评估SLFN5作为表观遗传疗法和基因组不稳定的预测生物标志物.

主要方法:

综合的多主题分析.
功能丰富分析. 功能丰富分析.
与临床结果和生物标志物的相关性分析.

主要成果:

升高的SLFN5表达与晚期瘤阶段,侵袭性瘤微环境和不良预后相关.
矛盾的是,SLFN5促进了调节性T细胞和巨细胞的透,同时提高了免疫检查点的调节.
SLFN5是表观遗传疗法 (BET/HDAC抑制剂) 的预测生物标志物,与瘤突变负担 (TMB) 和微卫星不稳定性 (MSI) 有关.

结论:

在各种癌症中,SLFN5是瘤进展和免疫逃避的关键调节者.
针对SLFN5提供治疗潜力,并为SLFN5高恶性瘤的组合免疫疗法策略提供信息.

关键词:

免疫检查站检查站胰腺癌是一种癌症.预测预测预测预测在SLFN5中使用.瘤微环境 (TME) 是指瘤的微环境.

更多相关视频

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Analyzing Tumor Gene Expression Factors with the CorExplorer Web Portal

Published on: October 11, 2019

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Dual-modality Molecular Cartography: Integrating Multiplex mRNA Detection with Protein Imaging Mass Cytometry

Published on: November 14, 2025

相关概念视频

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer-Critical Genes I: Proto-oncogenes

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...